Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$938K Sell
44,423
-695
-2% -$15.6K 0.02% 373
2017
Q1
$1.08M Buy
45,118
+3,551
+9% +$85.6K 0.02% 339
2016
Q4
$1.09M Sell
41,567
-23,988
-37% -$577K 0.02% 310
2016
Q3
$1.6M Sell
65,555
-4,000
-6% -$84.6K 0.03% 233
2016
Q2
$1.32M Sell
69,555
-6,200
-8% -$85K 0.03% 256
2016
Q1
$1.02M Sell
75,755
-441
-0.6% -$5.22K 0.02% 295
2015
Q4
$1.11M Buy
76,196
+5,641
+8% +$75.9K 0.02% 286
2015
Q3
$863K Buy
70,555
+2,600
+4% +$50.9K 0.02% 310
2015
Q2
$1.49M Sell
67,955
-7,255
-10% -$124K 0.03% 244
2015
Q1
$1.15M Buy
75,210
+29,469
+64% +$465K 0.02% 277
2014
Q4
$734K Buy
45,741
+6,822
+18% +$79.1K 0.01% 344
2014
Q3
$362K Buy
+38,919
New +$394K 0.01% 479

Other funds holding XNCR

Geneva Advisors's XNCR Position: Q2 2017 in Review

Geneva Advisors reduced its Xencor (XNCR) stake by 1.5% in Q2 2017, selling an estimated $15.6K and leaving 44,423 shares worth $938K. The position accounts for 0.02% of the portfolio, ranked #373.

Geneva Advisors first reported a position in XNCR in Q3 2014 and has held it in 12 quarters since. The position peaked at $1.6M in Q3 2016. 114 funds tracked by Wall St. Rank hold XNCR as of Q2 2017.

  • Geneva Advisors held 44,423 shares of Xencor worth $938K as of Q2 2017.
  • Geneva Advisors sold 695 Xencor shares in Q2 2017, an estimated $15.6K.
  • Xencor made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #373 holding.
  • Geneva Advisors first reported a position in Xencor in Q3 2014 and has held it in 12 quarters since.
  • Geneva Advisors's Xencor position peaked at $1.6M in Q3 2016.
  • 114 funds tracked by Wall St. Rank held Xencor as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.